I bought LABD last week based on this chart. The price closed above the supporting moving averages. The general markets are extended past 34 days in this cycle. Usually a market top happens about now.
Abbvie has been falling hard on news that it will sell off some drug patents in order to win approval for its merger with Allergan. It is entering a support zone between about $77 and $81, however, and it may start to climb from here as investors start to get excited about the merger. Also look for Coronavirus news to move the stock; word on the street is that one...
NNVC news Flu vaccine makers' stocks jump following the outbreak of coronavirus from China. World Health Organization accelerates diagnostics, vaccines, therapeutics for coronavirus. There are 2 main stocks trading on heavy volume caused directly by this new possible pandemic: CODX NNVC
Perfect close yesterday to bounce off support into a major move up! This is what we have been waiting for! Notes: -Stochastic: is sitting in a good spot: Neutral ( Not oversold or Over bought) -On Balance Volume: Still trending up on the daily very strong sign, especially with the price decline in the short term, The OBV hints at strong momentum still. -Falling...
A comany that is capable of designing a vaccine for coronavirus. It is difficult to say whether the price spike is due to the capability or their recent drug clinical trials succeeding.
Must stay above .35 or we go back down into the low .30's / high .20's. Stop loss set at .35 Not taking any chances with Sabby here.
If you like the analysis, Please Like and Follow me for more. View my previous post of Akorn inc. I evolved the bull flag slightly and found the bottom line the flag respects. An entry at current price would be ideal.
Friday's session presented a retracement on the 20 EMA Line, as predicted. I still believe in the continuation of the bullish trend. However, the bearish divergence needs to be monitored, since further price correction could occur. Disclosure: My ideas contain statements and projections based on assumptions on capital markets, and therefore inherently subject to...
Today's session generated a bearish divergence on CCI. I am still bullish, but always ready for a trend retracement on the 20 EMA Line. Disclosure: My ideas contain statements and projections based on assumptions on capital markets, and therefore inherently subject to numerous risks and uncertainties. Before buying or selling any stock you should do your own...
If you like this idea, don't forget to support it clicking the Like Button! Positive session for Nasdaq Healthcare that gained 0.39%. However, I still see the possibility of a retracement over the basis of the Bollinger Bands indicator (orange crosses). I was waiting with anxiety today's session to check for a signal of retracement, and it comes with the third...
Good session for the Nasdaq Healthcare Index, that closed the day with a 1.30% gain. Bullish sentiment is still driving trades. However next session could be characterized by a retracement around the basis of the Bollinger Bands indicator (orange crosses). This is a daily analysis. Disclosure: My ideas contain statements and projections based on assumptions on...
Lannett stock has struggled lately due to opioid litigation and a weakening of its earnings forecast back in November. However, the company announced several product launches in December and early January, and today Lannett got FDA approval for, of all things, a cocaine-based anesthetic nasal spray. The stock has shown little positive reaction to any of this news,...
After-hours today, McKesson raised its FY EPS guidance to 14.60-14.80, about 2% above the consensus analyst estimate of 14.41. Its last round of guidance was disappointing, so this reflects a significant improvement in the company's fundamentals. Even though the guidance bump was only 2%, it could catalyze a much larger move in the stock price, which was already...
I've been adding to my Alexion position since December 9, when I posted my previous idea on this stock. The wait is finally paying off, as the stock has surged higher in the past couple days. Alexion is getting unusually bullish call activity today, and the interest is more than justified at this forward P/E of less than 10 and PEG ratio of less than 1. Alexion...
Good spot for Alexion Pharmaceuticals. The stock is trading above the Ichimoku Cloud Support (red line of the green cloud). I was waiting for today's opening to confirm a bullish position. Furthermore, Alexion trades below its normal Price/Ebitda ratio of 41.13 (currently trading at 11.89). Disclosure: My ideas contain statements and projections based on...